
What factors drive the Asia Pacific’s Gaucher disease treatment market?
The sector is expected to hit $553.8m by 2034. The growing integration of genetic testing into national healthcare frameworks is driving the Asia Pacific’s Gaucher disease treatment market to reach $553.8m by 2034 at a compound annual growth rate of 3.2%, …